Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.
Richards
R
R
Burls
A
A
Payne
N
N
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D015331:Cohort Studies; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a